Top

Cancer Immunology, Immunotherapy

Published in:

01-08-2000 | ORIGINAL ARTICLE

Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer

Authors: Patrizia Pellegrini, Ida Contasta, Anna Maria Berghella, Estevano Gargano, Cesare Mammarella, Domenico Adorno

Published in: Cancer Immunology, Immunotherapy | Issue 7/2000

Title: Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer
Authors: Patrizia Pellegrini
Ida Contasta
Anna Maria Berghella
Estevano Gargano
Cesare Mammarella
Domenico Adorno
Publication date: 01-08-2000
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 7/2000
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s002620000129

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 7/2000

Killing of Fas ligand-resistant renal carcinoma cells by interleukin-2- and BCG-activated effector cells

Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels

Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

Local injections of OK432 can help the infiltration of adoptively transferred CD8+ T cells into the tumor sites and synergistically induce the local production of Th1-type cytokines and CXC3 chemokines

A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity

Keynote webinar | Spotlight on antibody–drug conjugates in cancer